1500 companies201–400 / 8 pages
| Ticker | Company | Country | Industry | Market | Revenue | FY |
|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $490.7mn | 2025 |
| 4521 | 科研製薬 | JP | Pharmaceuticals & Healthcare | Prime | ¥77bn | 2026 |
| NATR | NATURES SUNSHINE PRODUCTS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $480.1mn | 2025 |
| ZLAB | Zai Lab Ltd | CN | Pharmaceuticals & Healthcare | NASDAQ | $457.2mn | 2025 |
| 4886 | あすか製薬ホールディングス | JP | Pharmaceuticals & Healthcare | Prime | ¥71bn | 2026 |
| AORT | ARTIVION, INC. | US | Pharmaceuticals & Healthcare | NYSE | $441.3mn | 2025 |
| WGS | GeneDx Holdings Corp. | US | Pharmaceuticals & Healthcare | NASDAQ | $427.5mn | 2025 |
| MDXG | MIMEDX GROUP, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $418.6mn | 2025 |
| INVA | Innoviva, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $411.3mn | 2025 |
| ARDX | ARDELYX, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $407.3mn | 2025 |
| ARAY | ACCURAY INC | US | Pharmaceuticals & Healthcare | NASDAQ | $401.9mn | 2026 |
| IMCR | Immunocore Holdings plc | GB | Pharmaceuticals & Healthcare | NASDAQ | $400.0mn | 2025 |
| 4538 | 扶桑薬品工業 | JP | Pharmaceuticals & Healthcare | Prime | ¥62bn | 2026 |
| KRYS | Krystal Biotech, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $389.1mn | 2025 |
| SVA | SINOVAC BIOTECH LTD | CN | Pharmaceuticals & Healthcare | NASDAQ | $386.0mn | 2025 |
| CDNA | CareDx, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $379.8mn | 2025 |
| PHAR | Pharming Group N.V. | NL | Pharmaceuticals & Healthcare | NASDAQ | $376.1mn | 2025 |
| ARQT | Arcutis Biotherapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $372.1mn | 2025 |
| INMD | InMode Ltd. | IL | Pharmaceuticals & Healthcare | NASDAQ | $370.5mn | 2025 |
| MNKD | MANNKIND CORP | US | Pharmaceuticals & Healthcare | NASDAQ | $349.0mn | 2025 |
| CSTL | CASTLE BIOSCIENCES INC | US | Pharmaceuticals & Healthcare | NASDAQ | $344.2mn | 2025 |
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | US | Pharmaceuticals & Healthcare | NASDAQ | $329.5mn | 2025 |
| 4554 | 富士製薬工業 | JP | Pharmaceuticals & Healthcare | Prime | ¥52bn | 2025 |
| FLGT | Fulgent Genetics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $322.7mn | 2025 |
| DCGO | DocGo Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $322.2mn | 2025 |
| ANGO | ANGIODYNAMICS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $320.2mn | 2026 |
| 4577 | ダイト | JP | Pharmaceuticals & Healthcare | Prime | ¥51bn | 2026 |
| CRMD | CorMedix Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $311.7mn | 2025 |
| PRCT | PROCEPT BioRobotics Corp | US | Pharmaceuticals & Healthcare | NASDAQ | $308.1mn | 2025 |
| BLLN | BillionToOne, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $305.1mn | 2025 |
| SKIN | SkinHealth Systems Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $300.8mn | 2025 |
| EOLS | Evolus, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $297.2mn | 2025 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $296.2mn | 2025 |
| RIGL | RIGEL PHARMACEUTICALS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $294.3mn | 2025 |
| XERS | Xeris Biopharma Holdings, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $291.8mn | 2025 |
| — | Bavarian Nordic | DK | Pharmaceuticals & Healthcare | Nasdaq Copenhagen | DKK 1.9bn | 2021 |
| AUPH | Aurinia Pharmaceuticals Inc. | CA | Pharmaceuticals & Healthcare | NASDAQ | $283.1mn | 2025 |
| ADPT | Adaptive Biotechnologies Corp | US | Pharmaceuticals & Healthcare | NASDAQ | $277.0mn | 2025 |
| VCEL | Vericel Corp | US | Pharmaceuticals & Healthcare | NASDAQ | $276.3mn | 2025 |
| HROW | HARROW, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $272.3mn | 2025 |
| VMD | VIEMED HEALTHCARE, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $270.3mn | 2025 |
| LGND | LIGAND PHARMACEUTICALS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $268.1mn | 2025 |
| 4549 | 栄研化学 | JP | Pharmaceuticals & Healthcare | Prime | ¥42bn | 2026 |
| ARVN | ARVINAS, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $262.6mn | 2025 |
| OMDA | Omada Health, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $260.2mn | 2025 |
| SDGR | Schrodinger, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $255.9mn | 2025 |
| 4552 | ＪＣＲファーマ | JP | Pharmaceuticals & Healthcare | Prime | ¥40bn | 2026 |
| LMAT | LEMAITRE VASCULAR INC | US | Pharmaceuticals & Healthcare | NASDAQ | $249.6mn | 2025 |
| ACB | AURORA CANNABIS INC | CA | Pharmaceuticals & Healthcare | NASDAQ | CAD 343.3mn | 2025 |
| KROS | Keros Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $244.1mn | 2025 |
| KIDS | ORTHOPEDIATRICS CORP | US | Pharmaceuticals & Healthcare | NASDAQ | $236.3mn | 2025 |
| CERS | CERUS CORP | US | Pharmaceuticals & Healthcare | NASDAQ | $233.8mn | 2025 |
| 4548 | 生化学工業 | JP | Pharmaceuticals & Healthcare | Prime | ¥37bn | 2026 |
| PBYI | PUMA BIOTECHNOLOGY, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $228.4mn | 2025 |
| AXGN | Axogen, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $225.2mn | 2025 |
| IDYA | IDEAYA Biosciences, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $218.7mn | 2025 |
| VNDA | Vanda Pharmaceuticals Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $216.1mn | 2025 |
| AMRN | AMARIN CORP PLCUK | IE | Pharmaceuticals & Healthcare | NASDAQ | $213.6mn | 2025 |
| TMCI | TREACE MEDICAL CONCEPTS, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $212.7mn | 2025 |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | CR | Pharmaceuticals & Healthcare | NASDAQ | $211.1mn | 2025 |
| 4539 | 日本ケミファ | JP | Pharmaceuticals & Healthcare | Standard | ¥33bn | 2026 |
| CGC | Canopy Growth Corp | CA | Pharmaceuticals & Healthcare | NASDAQ | CAD 284.6mn | 2026 |
| SIBN | SI-BONE, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $200.9mn | 2025 |
| VALN | Valneva SE | FR | Pharmaceuticals & Healthcare | NASDAQ | €174.7mn | 2025 |
| LFMD | LifeMD, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $194.1mn | 2025 |
| LAKE | LAKELAND INDUSTRIES INC | US | Pharmaceuticals & Healthcare | NASDAQ | $192.6mn | 2026 |
| BTMD | biote Corp. | US | Pharmaceuticals & Healthcare | NASDAQ | $192.2mn | 2025 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $189.8mn | 2025 |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $185.7mn | 2025 |
| STOK | Stoke Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $184.4mn | 2025 |
| LFVN | Lifevantage Corp | US | Pharmaceuticals & Healthcare | NASDAQ | $182.6mn | 2026 |
| GLAS | Glass House Brands Inc. | US | Pharmaceuticals & Healthcare | NYSE | $182.0mn | 2025 |
| KMDA | KAMADA LTD | IL | Pharmaceuticals & Healthcare | NASDAQ | $180.5mn | 2025 |
| CYRX | Cryoport, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $176.2mn | 2025 |
| HTFL | Heartflow, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $176.0mn | 2025 |
| PHAT | Phathom Pharmaceuticals, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $175.1mn | 2025 |
| SBC | SBC Medical Group Holdings Inc | US | Pharmaceuticals & Healthcare | NASDAQ | $173.6mn | 2025 |
| SNDX | Syndax Pharmaceuticals Inc | US | Pharmaceuticals & Healthcare | NASDAQ | $172.4mn | 2025 |
| RGNX | REGENXBIO Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $170.4mn | 2025 |
| DNA | Ginkgo Bioworks Holdings, Inc. | US | Pharmaceuticals & Healthcare | NYSE | $170.2mn | 2025 |
| LQDA | Liquidia Corp | US | Pharmaceuticals & Healthcare | NASDAQ | $158.3mn | 2025 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | US | Pharmaceuticals & Healthcare | NASDAQ | $154.9mn | 2025 |
| AIRS | Airsculpt Technologies, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $151.8mn | 2025 |
| MGNX | MACROGENICS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $149.5mn | 2025 |
| STIM | Neuronetics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $149.2mn | 2025 |
| GRAL | GRAIL, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $147.2mn | 2025 |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | CN | Pharmaceuticals & Healthcare | NASDAQ | CN¥980.6mn | 2024 |
| CRON | Cronos Group Inc. | CA | Pharmaceuticals & Healthcare | NASDAQ | $146.6mn | 2025 |
| KPTI | Karyopharm Therapeutics Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $146.1mn | 2025 |
| INFU | InfuSystem Holdings, Inc | US | Pharmaceuticals & Healthcare | NYSE | $143.4mn | 2025 |
| NAII | NATURAL ALTERNATIVES INTERNATIONAL INC | US | Pharmaceuticals & Healthcare | NASDAQ | $142.5mn | 2026 |
| BEAM | Beam Therapeutics Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $139.7mn | 2025 |
| XTNT | Xtant Medical Holdings, Inc. | US | Pharmaceuticals & Healthcare | NYSE | $133.9mn | 2025 |
| NAGE | Niagen Bioscience, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $129.4mn | 2025 |
| GLUE | Monte Rosa Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $123.7mn | 2025 |
| ATRA | Atara Biotherapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $120.8mn | 2025 |
| 4565 | ネクセラファーマ | JP | Pharmaceuticals & Healthcare | Prime | ¥19bn | 2025 |
| OM | Outset Medical, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $119.5mn | 2025 |
| GYRE | GYRE THERAPEUTICS, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $116.6mn | 2025 |
| OSUR | ORASURE TECHNOLOGIES INC | US | Pharmaceuticals & Healthcare | NASDAQ | $115.0mn | 2025 |
| OGI | ORGANIGRAM GLOBAL INC. | CA | Pharmaceuticals & Healthcare | NASDAQ | CAD 159.8mn | 2024 |
| AGEN | AGENUS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $114.2mn | 2025 |
| IBRX | ImmunityBio, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $113.3mn | 2025 |
| ANIK | Anika Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $112.8mn | 2025 |
| URGN | UroGen Pharma Ltd. | IL | Pharmaceuticals & Healthcare | NASDAQ | $109.8mn | 2025 |
| IPSC | Century Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $109.2mn | 2025 |
| MTEX | MANNATECH INC | US | Pharmaceuticals & Healthcare | NASDAQ | $108.0mn | 2025 |
| MDXH | MDxHealth SA | BE | Pharmaceuticals & Healthcare | NASDAQ | $107.9mn | 2025 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $106.5mn | 2025 |
| ZYME | Zymeworks Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $106.0mn | 2025 |
| SMTI | Sanara MedTech Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $103.1mn | 2025 |
| BBNX | Beta Bionics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $100.3mn | 2025 |
| NPCE | NeuroPace Inc | US | Pharmaceuticals & Healthcare | NASDAQ | $100.0mn | 2025 |
| BFLY | Butterfly Network, Inc. | US | Pharmaceuticals & Healthcare | NYSE | $97.6mn | 2025 |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | US | Pharmaceuticals & Healthcare | NASDAQ | $95.1mn | 2026 |
| SIGA | SIGA TECHNOLOGIES INC | US | Pharmaceuticals & Healthcare | NASDAQ | $94.6mn | 2025 |
| 197A | タウンズ | JP | Pharmaceuticals & Healthcare | Standard | ¥14bn | 2026 |
| LUNG | Pulmonx Corp | US | Pharmaceuticals & Healthcare | NASDAQ | $90.5mn | 2025 |
| CBLL | Ceribell, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $89.1mn | 2025 |
| BDSX | BIODESIX INC | US | Pharmaceuticals & Healthcare | NASDAQ | $88.5mn | 2025 |
| CYTK | CYTOKINETICS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $88.0mn | 2025 |
| LAB | STANDARD BIOTOOLS INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $85.3mn | 2025 |
| DCTH | DELCATH SYSTEMS, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $85.2mn | 2025 |
| FDMT | 4D Molecular Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $85.2mn | 2025 |
| SPRY | ARS Pharmaceuticals, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $84.3mn | 2025 |
| NRIX | Nurix Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $84.0mn | 2025 |
| IRMD | IRADIMED CORP | US | Pharmaceuticals & Healthcare | NASDAQ | $83.8mn | 2025 |
| ARCT | Arcturus Therapeutics Holdings Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $82.0mn | 2025 |
| FTLF | FITLIFE BRANDS, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $81.5mn | 2025 |
| MGTX | MeiraGTx Holdings plc | US | Pharmaceuticals & Healthcare | NASDAQ | $81.4mn | 2025 |
| ADCT | ADC Therapeutics SA | CH | Pharmaceuticals & Healthcare | NYSE | $81.4mn | 2025 |
| BNR | Burning Rock Biotech Ltd | CN | Pharmaceuticals & Healthcare | NASDAQ | CN¥539.6mn | 2025 |
| TELA | TELA Bio, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $80.3mn | 2025 |
| 4524 | 森下仁丹 | JP | Pharmaceuticals & Healthcare | Standard | ¥13bn | 2026 |
| ETON | Eton Pharmaceuticals, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $80.0mn | 2025 |
| PDEX | PRO DEX INC | US | Pharmaceuticals & Healthcare | NASDAQ | $77.5mn | 2026 |
| SGHT | Sight Sciences, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $77.4mn | 2025 |
| CTMX | CytomX Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $76.2mn | 2025 |
| INCR | Intercure Ltd. | IL | Pharmaceuticals & Healthcare | NASDAQ | ILS 238.8mn | 2024 |
| AUTL | Autolus Therapeutics plc | GB | Pharmaceuticals & Healthcare | NASDAQ | $75.4mn | 2025 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $74.7mn | 2025 |
| ELMD | Electromed, Inc. | US | Pharmaceuticals & Healthcare | NYSE | $73.8mn | 2026 |
| CLLS | Cellectis S.A. | FR | Pharmaceuticals & Healthcare | NASDAQ | $72.9mn | 2025 |
| BCYC | BICYCLE THERAPEUTICS PLC | GB | Pharmaceuticals & Healthcare | NASDAQ | $72.6mn | 2025 |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $72.3mn | 2025 |
| 4595 | ミズホメディー | JP | Pharmaceuticals & Healthcare | Standard | ¥11bn | 2025 |
| RCEL | AVITA Medical, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $70.9mn | 2025 |
| VRDN | Viridian Therapeutics, Inc.\DE | US | Pharmaceuticals & Healthcare | NASDAQ | $70.8mn | 2025 |
| FOCL | EDAP TMS SA | FR | Pharmaceuticals & Healthcare | NASDAQ | $70.5mn | 2025 |
| BDTX | Black Diamond Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $70.0mn | 2025 |
| PSNL | Personalis, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $69.6mn | 2025 |
| RMTI | ROCKWELL MEDICAL, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $69.3mn | 2025 |
| VIR | Vir Biotechnology, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $68.6mn | 2025 |
| CCM | Concord Medical Services Holdings Ltd | CN | Pharmaceuticals & Healthcare | NYSE | CN¥454.3mn | 2025 |
| NTLA | Intellia Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $67.7mn | 2025 |
| KURA | Kura Oncology, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $67.5mn | 2025 |
| XGN | EXAGEN INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $66.6mn | 2025 |
| NUVB | Nuvation Bio Inc. | US | Pharmaceuticals & Healthcare | NYSE | $62.9mn | 2025 |
| 4512 | わかもと製薬 | JP | Pharmaceuticals & Healthcare | Standard | ¥10bn | 2026 |
| TNGX | Tango Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $62.4mn | 2025 |
| TRIB | TRINITY BIOTECH PLC | IE | Pharmaceuticals & Healthcare | NASDAQ | $61.6mn | 2024 |
| FBIO | Fortress Biotech, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $61.2mn | 2025 |
| DERM | Journey Medical Corp | US | Pharmaceuticals & Healthcare | NASDAQ | $61.2mn | 2025 |
| CSBR | CHAMPIONS ONCOLOGY, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $59.4mn | 2026 |
| APT | ALPHA PRO TECH LTD | CA | Pharmaceuticals & Healthcare | NYSE | $59.1mn | 2025 |
| AYTU | AYTU BIOPHARMA, INC | US | Pharmaceuticals & Healthcare | NASDAQ | $57.6mn | 2026 |
| CVRX | CVRx, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $56.7mn | 2025 |
| NKTR | NEKTAR THERAPEUTICS | US | Pharmaceuticals & Healthcare | NASDAQ | $55.2mn | 2025 |
| AGIO | AGIOS PHARMACEUTICALS, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $54.0mn | 2025 |
| QTTB | Q32 Bio Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $53.7mn | 2025 |
| APYX | Apyx Medical Corp | US | Pharmaceuticals & Healthcare | NASDAQ | $52.8mn | 2025 |
| PLX | Protalix BioTherapeutics, Inc. | US | Pharmaceuticals & Healthcare | NYSE | $52.7mn | 2025 |
| IRIX | IRIDEX CORP | US | Pharmaceuticals & Healthcare | NASDAQ | $52.7mn | 2026 |
| OCUL | OCULAR THERAPEUTIX, INC | US | Pharmaceuticals & Healthcare | NASDAQ | $52.0mn | 2025 |
| LNSR | LENSAR, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $51.7mn | 2025 |
| — | Zealand Pharma | DK | Pharmaceuticals & Healthcare | Nasdaq Copenhagen | DKK 343.0mn | 2023 |
| CARL | CARLSMED, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $50.5mn | 2025 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $49.8mn | 2025 |
| 4885 | 室町ケミカル | JP | Pharmaceuticals & Healthcare | Standard | ¥8bn | 2026 |
| GOSS | Gossamer Bio, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $48.5mn | 2025 |
| SI | SHOULDER INNOVATIONS, INC. | US | Pharmaceuticals & Healthcare | NYSE | $47.3mn | 2025 |
| PTGX | Protagonist Therapeutics, Inc | US | Pharmaceuticals & Healthcare | NASDAQ | $46.0mn | 2025 |
| SEPN | Septerna, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $46.0mn | 2025 |
| TLSI | TriSalus Life Sciences, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $45.2mn | 2025 |
| FENC | FENNEC PHARMACEUTICALS INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $44.6mn | 2025 |
| AQST | Aquestive Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $44.5mn | 2025 |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $44.5mn | 2025 |
| SNWV | SANUWAVE Health, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $44.1mn | 2025 |
| XLO | Xilio Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $43.8mn | 2025 |
| WVE | Wave Life Sciences, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $42.7mn | 2025 |
| SSII | SS Innovations International, Inc. | IN | Pharmaceuticals & Healthcare | NASDAQ | $42.5mn | 2025 |
| CHRS | Coherus Oncology, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $42.2mn | 2025 |
| BFRI | Biofrontera Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $41.7mn | 2025 |
| 4584 | キッズウェル・バイオ | JP | Pharmaceuticals & Healthcare | Growth | ¥7bn | 2026 |
| 4558 | 中京医薬品 | JP | Pharmaceuticals & Healthcare | Standard | ¥7bn | 2026 |
| KRMD | KORU Medical Systems, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $41.1mn | 2025 |
| MYO | MYOMO, INC. | US | Pharmaceuticals & Healthcare | NYSE | $40.9mn | 2025 |
| EDIT | Editas Medicine, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $40.5mn | 2025 |
| TKNO | Alpha Teknova, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $40.5mn | 2025 |
| 4574 | 大幸薬品 | JP | Pharmaceuticals & Healthcare | Prime | ¥6bn | 2025 |